# Argent BioPharma Positive Quarter Activity Report with CEO Roby Zomer (VIDEO)

- Link: https://www.directorstalkinterviews.com/argent-biopharma-positive-quarter-activity-report-with-ceo-roby-zomer-video/4121154603
- Published: 2024-05-02T07:40:56+01:00
- Author: Ethan Davis

Argent BioPharma Ltd (ASX:RGT) Managing Director and CEO of Argent BioPharma Roby
Zomer joins DirectorsTalk Interviews to discuss its Quarter Activity Report published
to the market.

In this interview Roby explains why a comprehensive restructuring process was undertaken
and what is different, how the company product portfolio is performing, the addition
of Dr. Shlomo Sadoun to the advisory board and how Roby sees the outlook for Argent
BioPharma.

Argent BioPharma Ltd, is an Australia-based drug discovery company focused on developing
and supplying accessible and ethically produced plant-derived medicines, combining
in-house research with technologies.

Share on:
